Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Saffron is a complex botanical substance classified as a Non-Standardized Plant Allergenic Extract and an Adrenergic Agonist. It is used clinically in hypersensitivity diagnostics and studied for its neuro-modulatory effects on serotonin and adrenergic receptors.
Name
Saffron
Raw Name
SAFFRON
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
31
Variant Count
41
Last Verified
February 17, 2026
About Saffron
Saffron is a complex botanical substance classified as a Non-Standardized Plant Allergenic Extract and an Adrenergic Agonist. It is used clinically in hypersensitivity diagnostics and studied for its neuro-modulatory effects on serotonin and adrenergic receptors.
Detailed information about Saffron
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Saffron.
Saffron, derived from the dried stigmas of the Crocus sativus flower, is a pharmacologically active botanical substance that occupies a unique position in modern clinical medicine. While widely recognized in culinary contexts, in the realm of clinical pharmacology, Saffron is formally classified under several Established Pharmacologic Classes (EPC), most notably as a Non-Standardized Plant Allergenic Extract [EPC] and a Non-Standardized Food Allergenic Extract [EPC]. Furthermore, regulatory databases and pharmacological profiles identify Saffron and its constituents as having properties consistent with alpha-Adrenergic Agonists [EPC], beta-Adrenergic Agonists [EPC], and Catecholamines [EPC]. This multifaceted classification reflects its use both as a diagnostic tool in allergy medicine and its systemic effects on the sympathetic nervous system.
Historically, Saffron has been utilized for millennia in traditional medicine, but its formal inclusion in drug databases stems from its role in hypersensitivity testing and its potent bioactive compounds—specifically crocin, crocetin, picrocrocin, and safranal. Unlike many standardized synthetic drugs, Saffron as an extract contains a matrix of carotenoids and terpenes that interact with the human physiology at multiple receptor sites. The FDA recognizes Saffron in the context of allergenic extracts used for skin prick testing and in vitro diagnostic procedures to identify patients with specific IgE-mediated sensitivities. It is important to note that while Saffron is available as a dietary supplement, its clinical application as a therapeutic agent for mood disorders and neuroprotection is the subject of ongoing rigorous clinical trials.
The mechanism of action (MoA) of Saffron is remarkably complex, involving several distinct pathways that justify its classification as an adrenergic modulator. At the molecular level, Saffron's primary bioactive components, such as safranal, exhibit significant affinity for the adrenergic system. Specifically, research indicates that these compounds can act as Adrenergic alpha-Agonists [MoA] and Adrenergic beta-Agonists [MoA]. By stimulating these receptors, Saffron can influence vascular tone, heart rate, and bronchial smooth muscle relaxation. This adrenergic activity is thought to be a contributing factor to its traditional use in respiratory conditions and its observed effects on blood pressure modulation.
Beyond the adrenergic system, Saffron acts as a potent modulator of neurotransmission. It has been shown to inhibit the reuptake of dopamine and norepinephrine, effectively acting as a natural catecholamine enhancer. In the central nervous system (CNS), crocin and safranal are believed to inhibit the reuptake of serotonin (5-HT), which explains the clinical interest in Saffron for the management of mild-to-moderate depression. Additionally, Saffron stigmas exhibit antagonistic activity at the GABA-A receptor complex, which may play a role in its sedative and anti-convulsant properties observed in pre-clinical models. The antioxidant capacity of crocin also provides a neuroprotective mechanism by scavenging free radicals and reducing neuroinflammation, which is a hallmark of many chronic neurological diseases.
Understanding the pharmacokinetics (PK) of Saffron is essential for determining its safety and efficacy. The PK profile is largely determined by the metabolism of its carotenoid constituents.
In the clinical setting, Saffron and its extracts are utilized for several indications, ranging from diagnostic to therapeutic:
Saffron is available in several pharmaceutical and supplemental preparations:
> Important: Only your healthcare provider can determine if Saffron is right for your specific condition. Because Saffron has potent adrenergic and serotonergic effects, it must be used under medical supervision, especially in patients with underlying cardiovascular or psychiatric conditions.
The dosage of Saffron varies significantly depending on the clinical indication and the specific formulation used. For therapeutic purposes, such as the management of mood or PMS, the standard adult dosage is typically 30 mg per day. This is often administered as 15 mg twice daily to maintain stable plasma levels of its active metabolites.
The safety and efficacy of Saffron in pediatric populations (children under 18 years of age) have not been extensively established. While some small studies have explored its use in children with ADHD at doses of 20-30 mg daily, Saffron is not currently FDA-approved for pediatric use. Parents and caregivers should never administer Saffron to a child without the explicit recommendation and supervision of a pediatrician or child psychiatrist.
Because Saffron metabolites are excreted renally, patients with significant kidney disease (Stage 3 or higher) should exercise caution. While specific dose reduction guidelines are not standardized, a lower starting dose (e.g., 15 mg once daily) may be appropriate to prevent accumulation.
Saffron undergoes hepatic metabolism. Patients with liver cirrhosis or impaired hepatic function may experience higher systemic exposure to crocetin. Monitoring for signs of toxicity (such as excessive drowsiness or hypotension) is recommended in this population.
Geriatric patients may be more sensitive to the adrenergic and sedative effects of Saffron. Clinical practice often involves starting at the lowest possible dose (15 mg daily) and titrating upward slowly while monitoring blood pressure and cognitive status.
To ensure optimal absorption and minimize potential side effects, patients should follow these administration guidelines:
If you miss a dose of Saffron, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up, as this may increase the risk of adrenergic side effects like palpitations or anxiety.
Saffron is considered safe at culinary and standard therapeutic doses (up to 1.5 grams per day). However, severe toxicity occurs at doses exceeding 5 grams. Signs of a Saffron overdose may include:
In the event of a suspected overdose, seek emergency medical attention immediately or contact a poison control center. Treatment typically involves gastric lavage and supportive care to manage blood pressure and hydration.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop taking Saffron without medical guidance, especially if you are using it for a diagnosed psychiatric condition.
While Saffron is generally well-tolerated at therapeutic doses, some patients may experience mild adverse reactions. These are typically transient and resolve as the body adjusts to the medication:
> Warning: Stop taking Saffron and call your doctor immediately if you experience any of the following serious symptoms:
The long-term safety of Saffron supplementation beyond 12 months has not been extensively studied in large clinical populations. Potential concerns with prolonged use include:
No FDA black box warnings currently exist for Saffron. However, it carries significant clinical warnings regarding its use in pregnancy and bipolar disorder due to its physiological potency.
Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring your reaction to Saffron is a critical part of ensuring your safety during treatment.
Saffron is a potent pharmacological agent and should not be viewed merely as a culinary spice when used in therapeutic concentrations. Its classification as an Adrenergic Agonist and Catecholamine modulator means it can significantly influence cardiovascular and neurological functions. Patients with pre-existing medical conditions must undergo a thorough medical evaluation before initiating Saffron therapy.
There are currently no FDA-mandated black box warnings for Saffron extracts. However, healthcare providers often treat the risk of miscarriage at high doses and the risk of mania in bipolar patients with the same level of clinical gravity as a boxed warning.
As a Non-Standardized Plant Allergenic Extract, Saffron carries a risk of severe allergic reactions. Patients who are allergic to plants in the Iridaceae family (such as irises or gladiolus) or the Liliaceae family (such as lilies, onions, or garlic) are at a significantly higher risk of cross-reactivity. Anaphylaxis, though rare, is a medical emergency that requires immediate intervention with epinephrine.
Saffron’s ability to increase serotonin and dopamine levels can be dangerous for individuals with bipolar disorder. Like many pharmaceutical antidepressants, Saffron may precipitate a shift from depression into mania or hypomania. Patients should be screened for a history of bipolar disorder before starting Saffron.
Due to its alpha and beta-adrenergic agonist properties, Saffron can affect heart rate and blood pressure. Individuals with unstable angina, arrhythmias, or uncontrolled hypertension should use Saffron only under strict cardiac monitoring. It may exacerbate tachycardia (rapid heart rate) in sensitive individuals.
Saffron may have anti-platelet properties. This is a major precaution for patients scheduled for surgery or those with bleeding disorders. Saffron should be discontinued at least 2 weeks prior to any elective surgical procedure to minimize the risk of excessive perioperative bleeding.
Patients taking Saffron for chronic conditions should undergo regular monitoring:
Saffron may cause dizziness or drowsiness in some individuals. Until you know how Saffron affects you, exercise extreme caution when driving, operating heavy machinery, or performing tasks that require full mental alertness. This effect may be magnified if Saffron is taken with alcohol or other sedating medications.
Alcohol should be avoided or strictly limited while taking Saffron. Alcohol can potentiate the sedative effects of Saffron and may increase the risk of dizziness and gastrointestinal irritation. Furthermore, alcohol’s effect on mood can counteract the therapeutic benefits of Saffron in patients being treated for depression.
While Saffron is not typically associated with a severe withdrawal syndrome, it is advisable not to stop taking it suddenly if you have been using it for a long period for mood management. A gradual taper over 1-2 weeks, under the guidance of a healthcare provider, can help prevent a relapse of depressive symptoms.
> Important: Discuss all your medical conditions, especially any history of heart disease, bleeding disorders, or psychiatric illness, with your healthcare provider before starting Saffron.
Certain medications should never be combined with Saffron due to the risk of severe, life-threatening interactions:
For each major interaction, the mechanism typically involves either pharmacodynamic synergy (additive effects on the same receptor system) or pharmacokinetic interference (competition for metabolic enzymes). The management strategy usually involves dose adjustment or avoiding the combination entirely.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication reconciliation is essential to prevent dangerous interactions.
In certain circumstances, the risks of Saffron use clearly outweigh any potential benefits. Saffron must NEVER be used in the following cases:
These conditions require a careful risk-benefit analysis and intensive medical supervision:
Patients should be aware of potential cross-sensitivity. If you have had an allergic reaction to the following, you may also be allergic to Saffron:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of allergies or psychiatric conditions, before determining if Saffron is a safe option for you.
Saffron is classified as potentially hazardous during pregnancy when taken in amounts exceeding those found in food.
It is not known whether the active metabolites of Saffron (crocetin) pass into human breast milk. Due to the lack of safety data and the potential for Saffron to affect the infant's developing nervous and cardiovascular systems (via its adrenergic activity), Saffron use is not recommended while breastfeeding. If a mother must take Saffron, the infant should be closely monitored for changes in sleep patterns, irritability, or feeding habits.
Saffron is not approved for use in children. The pediatric population is more sensitive to substances that alter neurotransmitter levels. There are concerns regarding the impact of long-term Saffron use on the developing brain and endocrine system. Clinical trials in children are sparse, and any use in this population is considered "off-label" and high-risk.
Elderly patients (aged 65 and older) may have reduced renal and hepatic clearance, leading to higher systemic levels of Saffron.
In patients with impaired kidney function, the excretion of glucuronidated crocetin metabolites is delayed. There are no established GFR-based dosing tables, but clinical caution dictates starting at 50% of the standard dose (e.g., 15 mg once daily) for patients with a GFR below 60 mL/min/1.73m². Saffron is not recommended for patients on hemodialysis due to a lack of clearance data.
Since the liver is the primary site for the metabolism of safranal and the glucuronidation of crocetin, patients with Child-Pugh Class B or C hepatic impairment should avoid Saffron. In mild impairment (Class A), monitoring for signs of carotenoid toxicity and excessive sedation is necessary.
> Important: Special populations require individualized medical assessment. Never start Saffron if you fall into one of these categories without a detailed discussion with your specialist.
Saffron's pharmacological profile is defined by its interaction with multiple receptor systems. As an Adrenergic alpha and beta-Agonist, it modulates the sympathetic nervous system. At the molecular level, safranal is thought to interact with adrenergic receptors to influence smooth muscle tone. Simultaneously, crocin acts as a potent antioxidant and a reuptake inhibitor of monoamines. It specifically inhibits the transporters for serotonin and norepinephrine, increasing the synaptic concentration of these neurotransmitters. Furthermore, Saffron components have shown the ability to modulate the NMDA (N-methyl-D-aspartate) receptor and the GABA-A receptor, contributing to its complex neuro-psychiatric effects.
| Parameter | Value |
|---|---|
| Bioavailability | Approximately 40-60% (as Crocetin) |
| Protein Binding | 90% - 95% (primarily to Albumin) |
| Half-life | 3 - 7 hours |
| Tmax | 1 - 2 hours (for Crocetin) |
| Metabolism | Hepatic (Hydrolysis and Glucuronidation); CYP3A4 involvement |
| Excretion | Renal (approx. 70%), Fecal (approx. 30%) |
Saffron is classified therapeutically as a botanical antidepressant and neuroprotective agent. Within regulatory frameworks, it is categorized as a Non-Standardized Plant Allergenic Extract and an Adrenergic Agonist. It is related to other monoamine-modulating botanicals like St. John's Wort, though its specific adrenergic mechanism distinguishes it from traditional herbal antidepressants.
Medications containing this ingredient
Common questions about Saffron
Saffron is primarily used in clinical settings as an allergenic extract for diagnosing specific plant and food allergies through skin testing. Beyond diagnostics, it is widely studied and used for its therapeutic effects on mild-to-moderate depression, premenstrual syndrome (PMS), and early-stage age-related macular degeneration. Its role as an adrenergic agonist also makes it a subject of interest for cardiovascular and respiratory research. However, it is not a first-line treatment for these conditions and should only be used under the guidance of a healthcare professional. Always consult your doctor to see if Saffron is appropriate for your specific medical needs.
The most common side effects reported by patients taking therapeutic doses of Saffron include nausea, dry mouth, dizziness, and changes in appetite. Some individuals may also experience mild headaches or a sense of drowsiness, especially when first starting the supplement. These symptoms are generally mild and often resolve as the body becomes accustomed to the extract. However, if these side effects persist or become bothersome, it is important to contact your healthcare provider. More serious side effects, though rare, require immediate medical attention.
It is generally recommended to avoid or strictly limit alcohol consumption while taking Saffron. Alcohol can increase the sedative effects of Saffron, leading to excessive drowsiness, impaired coordination, and an increased risk of falls, particularly in elderly patients. Additionally, alcohol may worsen the gastrointestinal side effects like nausea and can interfere with the mood-stabilizing benefits Saffron is intended to provide. Combining the two substances can also lead to unpredictable changes in blood pressure. Discuss your alcohol intake with your doctor before starting Saffron.
No, Saffron is not considered safe during pregnancy when taken in therapeutic or supplemental doses. Saffron has known oxytocic properties, which means it can stimulate uterine contractions and potentially lead to miscarriage or premature labor. While the small amounts of Saffron used in cooking are generally considered safe, concentrated extracts pose a significant risk to the pregnancy. Pregnant women should avoid Saffron supplements entirely and consult their obstetrician regarding any herbal products. Safety during breastfeeding is also not established.
The time it takes for Saffron to work depends on the condition being treated. For mood-related issues like depression or anxiety, it typically takes 2 to 4 weeks of consistent daily use before a significant therapeutic effect is noticed, which is a timeline similar to many prescription antidepressants. For premenstrual syndrome (PMS), benefits may be observed during the first or second cycle of use. However, some acute effects, such as a slight increase in alertness or heart rate due to its adrenergic properties, may be felt within an hour of taking a dose. Consistency is key for long-term benefits.
If you have been taking Saffron for an extended period, especially for mood management, you should not stop taking it suddenly without consulting your healthcare provider. While Saffron is not known to be addictive, a sudden discontinuation could potentially lead to a rapid return of depressive symptoms or anxiety. A gradual reduction in dosage, known as tapering, is often recommended to allow your neurotransmitter levels to stabilize. Your doctor can provide a safe schedule for stopping the medication to ensure your mental health remains stable throughout the process.
If you miss a dose of Saffron, you should take it as soon as you remember. If it is nearly time for your next scheduled dose, skip the missed one and continue with your regular routine. You should never take two doses at once to make up for a missed one, as this can increase the risk of side effects like palpitations, dizziness, or severe nausea. Maintaining a consistent schedule is important for the effectiveness of the treatment. If you frequently miss doses, consider using a pill organizer or setting a daily reminder on your phone.
Saffron is not typically associated with weight gain; in fact, some clinical studies suggest it may actually assist with weight management. Saffron has been shown to increase satiety (the feeling of fullness) and reduce the frequency of snacking by modulating serotonin levels, which can lead to a decrease in overall calorie intake. Some patients report a mild decrease in appetite while taking Saffron. However, weight changes can vary by individual, and any significant or unexpected weight gain or loss should be discussed with a healthcare provider to rule out other underlying causes.
Saffron can interact with several types of medications, so it is crucial to consult your doctor before combining it with other treatments. It may interact with antidepressants (increasing the risk of serotonin syndrome), blood pressure medications (due to its adrenergic effects), and blood thinners like aspirin or warfarin (increasing the risk of bleeding). It may also affect blood sugar levels, which is a concern for patients on diabetes medications. Always provide your healthcare provider with a full list of all prescription drugs, over-the-counter medicines, and supplements you are currently taking.
Saffron is a natural botanical substance and is not a 'branded' pharmaceutical drug in the traditional sense, so the concept of 'generic' vs. 'brand name' does not apply in the same way it does to synthetic medications. However, Saffron extracts are sold under many different brand names and as store-brand supplements. When choosing a Saffron product, it is important to look for one that is 'standardized' to contain a specific percentage of active ingredients like crocin or safranal. This ensures that you are receiving a consistent and potent dose, regardless of the manufacturer.